Bachem Holding AG - Company Profile

Powered by

All the data and insights you need on Bachem Holding AG in one report.

  • Save hours of research time and resources with
    our up-to-date Bachem Holding AG Strategy Report

  • Understand Bachem Holding AG position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

The following section provides information on Bachem Holding AG’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Bachem Holding AG's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Kuno Sommer

Chairman Executive Board Since: 2012 Age: 67

Mr. Kuno Sommer has been the Chairman of Bachem since 2012. Prior to this, he served as the Chief Executive Officer of Berna Biotech from 2000 to 2006. Previously, Dr. Sommer also held executive positions at Roche from 1986 to 1999. Currently, he serves as the Chairman of the board of Sunstar-Holding AG, Polyphor AG, PDS Pathology Data Systems AG, Kenta Biotech AG and TargImmune Therapeutics AG.

Read Hide full bio of Kuno Sommer

Thomas Meier

Chief Executive Officer Senior Management Since: 2020 Age: 54

Mr. Thomas Meier has been the Chief Executive Officer of Bachem since 2020. Prior to this, he served as Chief Operating Officer and a member of Corporate Executive Committee in 2019. Previously, Mr. Meier served as Chief Operating Officer Europe and with the responsibility of production sites of the company in Germany, Switzerland and the UK. He also served as the head of peptide manufacturing of Peninsula Laboratories, Inc. from 2001 to 2004. He joined Bachem AG in 1993.

Read Hide full bio of Thomas Meier

Alain Schaffter

Chief Financial Officer Senior Management Since: 2020

Mr. Alain Schaffter has been the Chief Financial Officer of Bachem since 2020. Prior to this, he worked as a consultant for several companies in the Life Science Industry, supporting them in specific projects like Reporting, IFRS conversion or IPO preparation and appointed as the Head of Special Finance Projects of Solvias AG in August 2018. Mr. Schaffter also served as the Head of Group Finance of Acino Group and Chief Financial Officer of Polyphor in 2016.

Read Hide full bio of Alain Schaffter

Roland Schurmann

Chief Operating Officer Senior Management Since: 2020 Age: 61

Mr. Roland Schurmann has been the Chief Operating Officer of Bachem since 2020. Prior to this, he served as the Vice President of manufacturing and Site Manager of Torrance at Bachem Americas, Inc. He joined Bachem Americas in 2016. Previously, he served at various senior level roles in Siegfried AG and became Head of Chemical Production in 2004. Previously, he worked as a chemical laboratory technician of Ciba-Geigy AG and as a production chemist of F. Hoffmann-La Roche Ltd from 1984 to 1997.

Read Hide full bio of Roland Schurmann

Gunther Loidl

Chief Technology Officer Senior Management Since: 2015 Age: 52

Mr. Gunther Loidl has been the Chief Technology Officer of Bachem since 2015. Prior to this, he held various functions in Active Pharmaceutical Ingredient Manufacturing and Research and Development of the company. Mr. Loidl joined the company in 2000 and served as the Vice President of Research and Development of the company in 2012.

Read Hide full bio of Gunther Loidl
Gain a 360-degree view of Bachem Holding AG and make more informed decisions for your business Gain a 360-degree view of Bachem Holding AG and make more informed decisions for your business Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Start of HubSpot Embed Code End of HubSpot Embed Code